Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: A prospective, randomized pilot study

Circulation

Volumn 98, Issue 19, 1998, Pages 2017-2023

  Dakik, Habib A ^a   Kleiman, Neal S ^a   Farmer, John A ^a,b   He, Zuo Xiang ^a   Wendt, Juliet A ^a   Pratt, Craig M ^a   Verani, Mario S ^a   Mahmarian, John J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Ischemia; Myocardial infarction; Tomography

Indexed keywords

ADENOSINE; DILTIAZEM; ISOSORBIDE DINITRATE; METOPROLOL TARTRATE; THALLIUM 201; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MIXTURE; FATIGUE; FEMALE; HEADACHE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TREMOR;

EID: 0032506089     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.19.2017     Document Type: Article

References (39)

1. Mahmarian JJ. Prediction of myocardium at risk: clinical significance during acute infarction and in evaluating subsequent prognosis. Cardiol Clin. 1995;13:355-378.
2. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol. 1995;25: 1333-1340.
3. The Persantine-Aspirin Reinfarction Study (PARIS) Research Group. The Persantine-Aspirin Reinfarction Study. Circulation. 1980;62:V85-V88.
4. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
5. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA. 1993;270:1589-1595.
6. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after myocardial infarction (the Danish Verapamil Infarction Trial II: DAVIT II). Am J Cardiol. 1990;66:779-785.
7. Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MJ, Schlant RC, Kleiger RE, Young PM, Schechtman K, Ferryman B, Roberts R, and the Diltiazem Reinfarction Study Group. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized, multicenter trial. N Engl J Med. 1986:315:423-429.
8. Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wasserman A, Robertson T, Ross R, and TIMI Investigators. One-year results of the Thrombolysis In Myocardial Infarction investigation (TIMI) phase II trial. Circulation. 1992;85: 533-542.
9. The SWIFT Investigators. SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction: SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. BMJ. 1991;302:555-560.
10. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med. 1996;335: 1198-1205.
11. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE, Sutherland W, Pilote L, Armstrong PW. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130-1135.
12. Mahmarian JJ, Pratt CM, Borges-Neto S, Cashion WR, Roberts R, Verani MS. Quantification of infarct size by T1-201 single-photon emission computed tomography during acute myocardial infarction in humans: comparison with enzymatic estimates. Circulation. 1988;78:831-839.
13. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68:785-795.
14. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease, II: subgroup with significant left main lesions. Circulation. 1976;54(suppl): III-I07-III-117.
15. The MIAMI Trial Research Group. Metoprolol In Acute Myocardial Infarction (MIAMI): mortality. Am J Cardiol. 1985;56:15G-22G.
16. Boden WE, Krone RJ, Kleiger RE, Oakes D, Greenberg H, Dwyer EJ Jr, Miller JP, Abrams J, Coromilas J, Goldstein R, Moss AJ, and the Multicenter Diltiazem Post-Infarction Trial Research Group. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. Am J Cardiol. 1991;67:335-342.
17. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction: the Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation. 1991;83:52-60.
18. Mahmarian JJ, Moye LA, Verani MS, Bloom MF, Pratt CM. High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography. Am J Cardiol. 1995;75:1116-1119.
19. Ellis SG, Mooney MR, George BS, da Suva EE, Talley JD, Flanagan WH, Topol EJ. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction: Treatment of Post Thrombolytic Stenoses (TOPS) Study Group. Circulation. 1992;86:1400-1406.
20. Rouleau JL, Moyé LA, Pfeffer MA, Arnold JMO, Bernstein V, Cuddy TE, Dagenais GR, Geltman EM, Goldman S, Gordon D, Hamm P, Klein M, Lamas GA, McCans J, McEwan P, Menapace FJ, Parker JO, Sestier F, Sussex B, Braunwald E, for the SAVE Investigators. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 1993:328:779-784.
21. Frishman W, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Circulation. 1988;77:774-786.
22. Subramanian VB, Bowles MI, Khurmi NS, Davies AB, Raftery EB. Rationale for the choice of calcium antagonists in chronic stable angina: an objective double-blind placebo-controlled comparison of nifedipine and verapamil. Am J Cardiol. 1982:50:1173-1179.
23. Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart]. 1991;121:1361-1366.
24. Mahmarian JJ, Fenimore NL, Marks GF, Francis MJ, Morales-Ballejo H, Verani MS, Pratt CM. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a doubleblind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol. 1994;24:25-32.
25. Stegaru B, Loose R, Keller H, Buss J, Wetzel E. Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion. Am J Cardiol. 1988;61:74E-77E.
26. Shehata AR, Gillam LD, Mascitelli VA, Herman SD, Ahlberg AW, White MP, Chen C, Waters DD, Heller GV. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol. 1997;80:268-272.
27. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, Pratt C, Stone PH, Davies RF, Rogers WJ, Deanfield JE, Goldberg AD, Ouyang P, Mueller H, Sharaf B, Day P, Selwyn AP, Conti CR, for the ACIP Investigators. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol. 1994;24:11-20.
28. Pratt CM, McMahon RP, Goldstein S, Pepine CJ, Andrews TC, Dyrda I, Frishman WH, Geller NL, Hill JA, Morgan NA, Stone PH, Knatterud GL, Sopko G, Conti CR, for the ACIP Investigators. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). Am J Cardiol. 1996:77:1302-1309.
29. Madsen JK, Grande P, Saunamäki K, Thayssen P, Kassis E, Eriksen U, Rasmussen K, Haunso S, Nielsen TT, Haghfelt T, Fritz-Hansen P, Hjelms E, Paulsen PK, Alstrup P, Arendrup H, Niebuhr-Jørgensen U, Andersen LI, on behalf of the DANAMI Study Group. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation. 1997;96:748-755.
30. Mahmarian JJ, Moye LA, Nasser GA, Nagueh SF, Bloom MF, Benowitz NL, Byrd WG, Pratt CM. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cordial. 1997;30:125-130.
31. Sharir T, Livschitz S, Rabinowitz B, Chouraqui P. Anti-ischemic drugs reduce size of reversible defects in dipyridamole/submaximal exercise Tl-201 SPECT imaging. J Nucl Cardiol. 1997;4:S71. Abstract.
32. Fallen EL, Nahmias C, Scheffel A, Coates G, Beanlands R, Gamett ES. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation. 1995;91:1381-1388.
33. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation. 1981;64:1089-1097.
34. He ZX, Medrano R, Hays JT, Mahmarian JJ, Verani MS. Nitroglycerinaugmented T1-201 reinjection enhances detection of reversible myocardial hypoperfusion: a randomized, double-blind, parallel, placebocontrolled trial. Circulation. 1997;95:1799-1805.
35. Boucher M, Czernin J, Sun K, Phelps ME, Scheiben HR. Effect of Bl adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med. 1997;38:442-446f
36. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, Masters RG, Moisa RB, Mueller H, Pearce DJ, Pepine CJ, Sopko G, Steingart RM, Stone PH, Knatterud GL, Conti CR, for the ACIP Investigators. Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol. 1995;26:594-605.
37. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U, for the ASIST Study Group. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: the Atenolol Silent Ischemia Study (ASIST). Circulation. 1994;90:762-768.
38. Parisi AF, Hartigan PM, Folland ED, for the ACME Investigators. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease: findings from the Angioplasty Compared to Medicine (ACME) study. J Am Coll Cardiol. 1997; 30:1256-1263.
39. Bourassa MG, Pepine CJ, Forman SA, Rogers WJ, Dyrda I, Stone PH, Chaitman BR, Sharaf B, Mahmarian J, Davies RF, Knatterud GL, Terrin M, Sopko G, Conti R, for the ACIP Investigators. Effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. J Am Coll Cardiol. 1995;26:606-614.